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Patrick O Brown, known as Pat, did his undergraduate 
and medical training at the University of Chicago, where 
he also studied under Nicholas Cozzarelli for his PhD. He 
was a paediatrics resident at Children’s Memorial 
Hospital, before taking a postdoctoral research position 
with Michael Bishop and Harold Varmus at the 
University of California at San Francisco. He 
subsequently moved to Stanford where he played an 
instrumental part in the development of microarray 
technology and its applications and where he is now a 
Professor of Biochemistry and Howard Hughes Medical 
Institute investigator.
Pat has a long association with BioMed Central, dating 
from its origins at the beginning of the open access 
movement, and is on the Editorial Board of BMC Biology; 
so we asked him to give his own perspective on open 
access and how it began.
Do you remember how and when the idea of open 
access first occurred to you?
It occurred to me in a kind of a roundabout way. I had 
been working on studies that involved looking at the 
expression of thousands or tens of thousands of genes 
under hundreds of different physiological conditions and 
in different developmental states, mostly in yeast, some 
in humans, so we had in our hands data sets that 
consisted of millions of quantitative measurements of 
gene expression that you can think of as a map that 
relates physiology and development and disease to 
patterns of expression of thousands or tens of thousands 
of genes.
This was in the very early years of microarrays?
Yes. Some of that data is interpretable without any 
external information, but its value is hugely enhanced if 
we can use it as a way of linking on the one hand things 
that we already know about physiological systems or 
developmental systems or diseases or particular tissue 
cell types, and on the other hand whatever we already 
know about the genes or their products: the links that are 
provided by those millions of data points in the gene 
expression arrays add a huge amount of value to existing 
information.
So every time we did an experiment my colleagues and 
I found ourselves digging up hundreds of papers to 
educate ourselves about things that we were seeing in the 
data. By that time a substantial fraction of the journals 
that were most relevant to what we were doing were 
being published online and since we were at Stanford we 
had access to at least most of them, but we knew we were 
not getting full value out of our data, first because we still 
didn’t have ready access to all the available knowledge 
that was published somewhere and would enable us to 
make better sense of it. Equally importantly, the manual 
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search for published information that could add value to 
our data was unscalable. So we wanted to put the entire 
corpus of relevant articles in a database that would let us 
automate the process, but we were thwarted by 
publishers who strictly forbade downloading and 
automated analysis.
That led me to ask why should publishers be able to 
control what I can do with information that was 
published by my scientific colleagues whose motivation 
was exactly to have their discoveries contribute to future 
discoveries? And it became obvious that there were 
things about the way the scientific literature was 
organized that were anachronistic in 1997 when we had 
already existing tools that we could use to so to speak 
hyperlink things so that you could reorganize information 
in systematic ways, but they weren’t really being exploited 
by the conventional scientific literature.
Then at about that time my lab had published a paper 
that involved a lot of supplementary information that we 
posted online the main server at Stanford, which was 
used by maybe a hundred scientists at Stanford, and more 
than half of all the bandwith of the server was taken up 
by people downloading our data. And so I thought OK 
well actually we should just stop publishing in journals 
altogether, and when we have something to report we’ll 
just post it up on this server and spread the word and 
bypass the whole annoying experience of publishing in 
journals, and just let the world decide if what we have is 
interesting. Well that was kind of a primitive idea but…
This is something that physicists were already 
doing…
I was just about to say that. At the time I wasn’t aware of 
what was then called the XXX.LANL preprint server 
[now arXiv.org] that Paul Ginsparg had created, but it 
was very close to that kind of thing that I had in mind. 
Paul had started a little server as an informal mechanism 
for exchanging preprints in his small community that just 
grew organically because it was such a useful thing.
So your idea was that there was no reason why this 
couldn’t be extended to biological sciences?
Yes. The way the existing journal system operated was 
completely unsuited to very data intensive research 
where the real need is to be able to use large systematic 
datasets as a way of providing links between disparate 
bits of information.
And it was about that time that you started 
talking to people, including Vitek Tracz, who 
founded BioMed Central, about how to change the 
publishing world.
Yes. I don’t remember the exact timing, but I do 
remember talking relatively early on in the process with 
Vitek and also with David [Lipman], and a few months 
later when I was organizing a genomics meeting with 
Gerry Rubin at Banbury [the Banbury Center at Cold 
Spring Harbor] I set up a session to which I invited David 
and Paul Ginsparg – because they hadn’t met – with the 
intention to brainstorm about how we could transform 
scientific publishing.
Then around the same time Harold Varmus, who was 
then Director of the NIH – he was a friend of mine 
because he’d been my postdoc advisor some years before, 
and a fellow non-conformist personality was coming out 
to San Francisco, so I met him at a coffee shop, and went 
through the idea of setting up a NIH hosted server where 
scientists could post their work when they felt it was 
ready to share with the world, and where it would be 
organized in a systematic way. David Lipman and I had 
already started having conversations about things that 
still actually haven’t come to pass, discussing how one 
could make the system work. I still think they’re good 
ideas, but...anyway, the upshot of it was that Harold was 
quite receptive and organized a follow-on meeting at 
NIH, and there was a lot of enthusiastic support, and 
from people of all stripes: it wasn’t just a bunch of 
genome geeks and bioinformatic types.
And then over the next month or so Harold and I were 
bouncing back and forth by e-mail some documents 
about how this system might operate and what it could 
try to accomplish, and then Harold sent around to some 
publishers and societies, and also posted on the Director’s 
website a proposal for something that was dubbed 
e-Biomed. It’s still up there, at http://www.nih.gov/about/
director/pubmedcentral/ebiomedarch.htm.
It is still up there, and what it makes clear is 
that once the idea of open access started to be 
developed, it was very much in the model of 
subscription-based print publishing, with peer 
review and so forth, which was not what you 
originally had in mind.
Absolutely not. What we had in mind originally was 
much more radical in every way. And I should say those 
of us who have been involved in this for some time have 
absolutely not given up on this, it’s just been more slow 
and incremental than we had wished.
But what about open access itself – doesn’t it seem 
that open access has gained ground so fast that that 
battle is now all but won?
Well let’s put it this way: I think the tipping point was 
reached quite a while ago, and so in that sense it’s won: I 
think that there’s absolutely no going back: there’s a 
relentless ratchet effect so that step after step after step 
the subscription business model is becoming less and less 
sustainable, and the notion of open access publishing as 
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the only right way to do things is becoming pretty well 
established I would say in the scientific community, and I 
think most of the existing publishers recognize that.
So we’re left with the issue of how to escape from 
the current peer review model – do you see that as 
the next frontier?
The thing that is most sick right now, besides the 
continued existence of restricted access, is the delay 
between an important discovery or idea or publishable 
body of information and its actual publication. For 
example, when a scientist makes an observation that’s the 
genesis of a new way to treat an important disease and 
submits it to a journal, nobody sees that paper until nine 
months later. Nine months later someone sees it, takes 
the next step, submits their own paper and it finally 
comes out another nine months later. Do a few cycles of 
that and something that, let’s say, can save millions of 
lives actually becomes available two years later than it 
had to, entirely because of a delay between a discovery 
being made and its being shared with the world. And 
that’s the situation we’re in now. That delay is the 
opportunity cost we pay for requiring peer-review before 
publication. I’m all for peer review, but I’m not for way 
it’s done now. You could have the peer review process – 
or a better peer review process – AFTER a paper has 
been published.
But let me just take a step back and say one thing: when 
we first started thinking about open access there were a 
lot ideas about how to fix scientific publishing, but we all 
realized quickly that by far the most important was open 
access. That was the sine qua non for everything else we 
wanted – to have the scientific literature be available 
unrestricted, to anyone to use in any way they wanted. 
Once you have that, then you not only make the benefits 
of the published research available to the whole world, 
but you have the potential for all kinds of 
experimentation, for building new tools, news ways of 
structuring the information, and so on.
Do you think that has yet been fully exploited?
It’s not fully exploited, though I think it’s almost at the 
point where it will be, because for people to invest in 
building new systems for organizing and navigating the 
information you have to have a critical mass of raw 
material. You can’t have a patchwork. And I think the 
open access literature at this point is approaching a 
critical mass where that body of information is enough to 
allow us to ignore all the non-open access literature. We’ll 
reach a point where there’s a positive feedback loop: with 
enough information, people will develop tools to make 
open-access information more valuable, and then it will 
become increasingly more valuable than the restricted-
access information because it’s not only accessible but it’s 
had value added to it in ways that can’t be applied to the 
restricted-access material, so that non-open access 
becomes progressively marginalized, and nobody wants 
to be in that space.
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